References
- Cutarelli P. E., Lass J. H., Lazarus H. M. Topical fluoroquinolones: Antimicrobial activity and in vitro corneal epithelial toxicity. Curr. Eye Res. 1991; 10: 557–563
- Hobden J. A., Reidy J. J., O'Callaghan R. J. Quinolones in collagen shields to treat aminoglycoside-resistant pseudomonal keratitis. Invest. Ophthalmol. Vis. Sci. 1990; 31: 2241–2243
- O'Brien T. P., Sawusch M. R., Dick J. D. Topical ciprofoloxacin treatment of Pseudomonas keratitis in rabbits. Arch. Ophthalmol. 1988; 106: 1444–1446
- Goldstein E. J. G., Citron D. M., Bendon L. Potential of topical norfloxacin therapy: Comparative in vitro activity against clinical ocular bacterial isolates. Arch. Ophthalmol. 1987; 105: 991–994
- Wolfson J. S., Hooper D. C. The fluoroquinolones: Structures, mechanism of action and resistance, and spectra of activity, in vitro. Antimicrob. Agents Chemother. 1985; 28: 581–586
- Hooper D. C., Wolfson J. S. The fluoroquinolones: Pharmacology, clinical uses, and toxicities in humans. Antimicrob. Agents Chemother. 1985; 28: 716–721
- Wolfson J. S., Hooper D. C. Overview of fluoroquinolone safety. Am. J. Med. 1991; 91(6A)153S–159S